CARDIOPHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 13966273
Bregnevej 39, 2820 Gentofte
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | 2 396.66 | 811.19 | 3 438.35 | 437.95 | 2 618.26 |
Gross profit | 2 396.66 | 811.19 | 3 438.35 | 437.95 | 2 618.26 |
Costs of management | - 299.56 | - 107.15 | - 252.91 | -90.13 | -61.89 |
EBIT | 2 097.10 | 704.05 | 3 185.44 | 347.83 | 2 556.37 |
Other financial income | 158.43 | 3 672.63 | 45.28 | 414.50 | 657.57 |
Other financial expenses | - 962.46 | - 156.34 | - 581.26 | -2.87 | - 355.14 |
Income from other inv. held as non-curr. assets | 285.31 | 59.69 | 253.04 | 262.77 | 51.85 |
Pre-tax profit | 1 578.39 | 4 280.02 | 2 902.51 | 1 022.22 | 2 910.65 |
Income taxes | -3.76 | -1.44 | -1.82 | -3.58 | -0.34 |
Net earnings | 1 574.63 | 4 278.59 | 2 900.69 | 1 018.64 | 2 910.30 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Tangible assets total | |||||
Participating interests | 2 147.48 | 2 147.48 | 2 147.48 | 2 147.48 | 2 147.48 |
Investments total | 2 147.48 | 2 147.48 | 2 147.48 | 2 147.48 | 2 147.48 |
Non-current loans receivable | 8 443.97 | 12 778.21 | 17 426.21 | 18 385.67 | 19 266.61 |
Non-current other receivables | 1 823.53 | 1 888.23 | 1 739.39 | 1 785.21 | 1 809.15 |
Long term receivables total | 10 267.50 | 14 666.44 | 19 165.60 | 20 170.88 | 21 075.76 |
Inventories total | |||||
Current deferred tax assets | 100.10 | 60.41 | 68.61 | 66.21 | 62.32 |
Short term receivables total | 100.10 | 60.41 | 68.61 | 66.21 | 62.32 |
Other current investments | 8 487.88 | 12 582.17 | 5 415.34 | 3 577.01 | 3 757.00 |
Cash and bank deposits | 5 244.85 | 668.05 | 1 276.32 | 2 160.42 | 1 260.45 |
Cash and cash equivalents | 13 732.73 | 13 250.22 | 6 691.66 | 5 737.43 | 5 017.45 |
Balance sheet total (assets) | 26 247.81 | 30 124.56 | 28 073.35 | 28 121.99 | 28 303.02 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
Shares repurchased | 400.00 | 5 000.00 | 1 000.00 | 700.00 | 3 675.00 |
Other reserves | -1 950.00 | ||||
Retained earnings | 24 102.45 | 20 677.08 | 23 955.66 | 26 156.35 | 23 499.99 |
Profit of the financial year | 1 574.63 | 4 278.59 | 2 900.69 | 1 018.64 | 2 910.30 |
Shareholders equity total | 26 202.08 | 30 080.66 | 27 981.35 | 27 999.99 | 28 260.29 |
Non-current liabilities total | |||||
Current owed to participating | 1.70 | 1.70 | 50.00 | 0.72 | |
Other non-interest bearing current liabilities | 44.04 | 42.20 | 42.00 | 122.00 | 42.00 |
Current liabilities total | 45.73 | 43.89 | 92.00 | 122.00 | 42.72 |
Balance sheet total (liabilities) | 26 247.81 | 30 124.56 | 28 073.35 | 28 121.99 | 28 303.02 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.